Informed Genomics - Comprehensive Hereditary Cancer Panel
Our hereditary cancer clinical service at Informed Genomics aims to identify individuals at a higher-than-population risk for hereditary cancer. We offer a range of hereditary cancer panels to study genes associated with the most common hereditary cancers ranging from a comprehensive multi-cancer panel to targeted panels for breast, ovarian, colorectal, prostate, melanoma and pancreatic cancer.
The panels have been expertly curated using current literature and national testing guidelines to maximise clinical actionability, whilst minimising uncertainty. Our routine turnaround time for this testing is 3-4 weeks, however, prioritisation options are available. Please contact us to discuss your requirements.
The final clinical report summarises test results by providing variant interpretation, the implications of the results, and any recommended actions. Full genetic counselling is available for patients to explain test results and the associated implications, and to inform relevant support networks. Click here for further information on the clinical report.
Standard Turnaround time: 14days (and 2 days transport via post)
Priority Turnaround time: 10days (and 1 day transport via DHL)
Breast Cancer
Hereditary Breast Cancer Panel ATM1, BARD1, BRCA1, BRCA2, CHEK22, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53 Hereditary Breast and Gynaecological Cancer Panel ATM1, BARD1, BRCA1, BRCA2, BRIP1, CHEK22, EPCAM3, MLH1, MSH2, MSH6, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53 Further information regarding these genes can be found here
